How do sex hormones and birth control affect brain fear circuits?

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

Am­gen re­leased new Phase 3 da­ta Wednes­day for its rare dis­ease drug Up­liz­na in an au­toim­mune con­di­tion, bring­ing it po­ten­tial­ly clos­er to an­oth­er FDA ap­proval